FORMULATION, DEVELOPMENT, CHARACTERIZATION AND EVALUATION OF TOLMETIN AND TIZANIDINE LOADED TRANSDERMAL PATCHES FOR ANTIINFLAMMATORY ACTIVITY
International Journal of Drug Delivery Technology · 18.06.2026 · 16 (55s)
DOI: 10.25258/ijddt.16.55s.133 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 18.06.2026. Verfasst von Dolly Shukla und 2 weiteren Autor:innen.
Abstract (Originalsprache)
The present study was undertaken to formulate and evaluate Tolmetin and Tizanidine loaded transdermal patches for anti-inflammatory activity. Tolmetin is a non-steroidal anti-inflammatory drug possessing analgesic and antiinflammatory properties, while Tizanidine is a centrally acting muscle relaxant used for the management of painful musculoskeletal conditions. The combination of both drugs in a transdermal patch may provide sustained drug release, improved patient compliance, reduced dosing frequency, and avoidance of first-pass metabolism. Matrix-type transdermal patches were prepared by the solvent casting method using different ratios of polymers such as HPMC, ethyl cellulose, Eudragit, PVP, and plasticizer. Nine formulations were developed and coded as F1–F9. The prepared patches were evaluated for physicochemical parameters such as physical appearance, thickness, weight variation, folding endurance, moisture content, moisture uptake, surface pH, drug content, tensile strength, flatness, in vitro drug release, ex vivo permeation, skin irritation study, and stability studies. Tizanidine is a centrally acting muscle relaxant that relieves muscle spasms by acting on alpha 2 receptors in the spinal cord. Their combination was expected to provide synergistic anti inflammatory and muscle relaxant effects. Transdermal patches were prepared by solvent casting method using different ratios of polymers such as hydroxypropyl methylcellulose (HPMC) and ethyl cellulose (EC) with dibutyl phthalate as plasticizer. Nine formulations (F1–F9) were developed and evaluated for physicochemical parameters such as thickness, weight uniformity, drug content, folding endurance, moisture content, moisture uptake, in vitro drug release, ex vivo permeation, and stability. All formulations showed satisfactory appearance, uniform thickness, and good flexibility. Drug content ranged from 93.45% to 98.92%. In vitro drug release studies demonstrated sustained release up to 24 h, with formulation F5 showing maximum cumulative drug release (96.78% for Tolmetin and 95.42% for Tizanidine). Anti inflammatory activity evaluated by protein denaturation assay showed significant inhibition, with formulation F5 exhibiting 71.23% inhibition comparable to Diclofenac gel (73.89%). In vivo carrageenan induced paw edema studies in Albino Wistar rats also confirmed significant anti inflammatory activity. The developed Tolmetin and Tizanidine loaded transdermal patch may serve as a safe and effective combination therapy for inflammatory conditions with muscle spasm.
Zitieren
APA
Shukla, D., Sharma, M., & Sharma, A. K. (2026). FORMULATION, DEVELOPMENT, CHARACTERIZATION AND EVALUATION OF TOLMETIN AND TIZANIDINE LOADED TRANSDERMAL PATCHES FOR ANTIINFLAMMATORY ACTIVITY. International Journal of Drug Delivery Technology, 16(55s). https://doi.org/10.25258/ijddt.16.55s.133
Vancouver
Shukla D, Sharma M, Sharma AK. FORMULATION, DEVELOPMENT, CHARACTERIZATION AND EVALUATION OF TOLMETIN AND TIZANIDINE LOADED TRANSDERMAL PATCHES FOR ANTIINFLAMMATORY ACTIVITY. International Journal of Drug Delivery Technology. 2026;16(55s). doi:10.25258/ijddt.16.55s.133
BibTeX
@article{Shukla2026,
author = {Shukla, Dolly and Sharma, Manmohan and Sharma, Amit Kumar},
title = {FORMULATION, DEVELOPMENT, CHARACTERIZATION AND EVALUATION OF TOLMETIN AND TIZANIDINE LOADED TRANSDERMAL PATCHES FOR ANTIINFLAMMATORY ACTIVITY},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {55s},
doi = {10.25258/ijddt.16.55s.133}
}
EUVIMED